Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Researchers' work adds to cancer therapy body of knowledge
May 26th, 2005
Cancer therapy data are the focus of recent research from the United States. Study 1: Cyclooxygenase-2 inhibitor battles metastatic breast cancer cells. "Cyclooxygenase-2 (COX-2) inhibitors are rapidly emerging as a new generation of therapeutic drug in combination with chemotherapy or radiation therapy for the treatment of cancer. The mechanisms underlying its antitumor effects are not fully understood and more thorough preclinical trials are needed to determine if COX-2 inhibition represents a useful approach for prevention and/or treatment of breast cancer," scientists in the United States report. "The purpose of this study was...
Source: Women's Health Weekly (2005-05-26)
|
